Announcements Trials
Browse Landscape

Status

Completed 6Unknown 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 19Observational 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 2Breast Cancer Organoids 1

Interventions

Blood Specimen Collection 85Surveys and Questionnaires 83Surgical Procedures, Operative 44Drug Therapy 32Radiotherapy 27Biopsy 26Amplified Fragment Length Polymorphism Analysis 24Neoadjuvant Therapy 23Immunohistochemistry 22Gene Expression Profiling 21Bevacizumab 19Data Collection 18Immunotherapy 17Ultrasonography 16Positron Emission Tomography Computed Tomography 16Magnetic Resonance Spectroscopy 16Liquid Biopsy 16pembrolizumab 15Nivolumab 15Watchful Waiting 14Radiosurgery 14Observation 14Microarray Analysis 14Magnetic Resonance Imaging 14Interviews as Topic 14Immune Checkpoint Inhibitors 13Colonoscopy 13Capecitabine 13Polymerase Chain Reaction 12Paclitaxel 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Observational × eribulin × Clear all
NCT04683445 2020-12-24

Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown
80 enrolled
Breast

Breast Neoplasms

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Xijing Hospital

Unknown
300 enrolled
Breast

Breast Cancer Organoids

NCT03245112 2017-08-16

Halaven Patient Registry (Metastatic Breast Cancer, MBC)

Chang Gung Memorial Hospital

Unknown
500 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡